Personal information

Emails & domains

Verified email domains

Websites & social links

Linkedin

Other IDs

Scopus Author ID: 56351042100

Countries

Spain

Activities

Collapse all

Employment (3)

Institut de Recerca de Sant Pau: Barcelona, Barcelona, ES: Barcelona, Barcelona, ES

2022-01-02 to present | Responsable de Unidad (Unidad de Investigación e Innovación Responsable)
Employment
Source: Self-asserted source
maria rosa ballester

Ramon Llull University: Barcelona, Barcelona, ES

2014-09-12 to present | Profesor asociado (Facultad Ciencias de la Salud)
Employment
Source: Self-asserted source
maria rosa ballester

Institut Investigació Biomèdica Sant Pau: Barcelona, Barcelona, ES: Barcelona, Barcelona, ES: Barcelona, Barcelona, ES

2008-01 to 2022-01 | Investigadora (Centro de Investigación de Medicamentos)
Employment
Source: Self-asserted source
maria rosa ballester

Education and qualifications (5)

Universitat Autònoma de Barcelona: Barcelona, Catalunya, ES

2006-05 to 2016-02-05 | Doctor (CIM-SantPau)
Education
Source: Self-asserted source
maria rosa ballester

Universitat Autònoma de Barcelona: Bellaterra, Catalunya, ES

2006-09 to 2008-06 | Medicina de la Industria Farmaceutica (Farmacologia)
Education
Source: Self-asserted source
maria rosa ballester

Universitat Autònoma de Barcelona: Bellaterra, Catalunya, ES

2001-09 to 2003-02 | Diploma d'Estudis Avançats (Farmacologia)
Education
Source: Self-asserted source
maria rosa ballester

Universitat Pompeu Fabra: Barcelona, Catalunya, ES

2001-09 to 2002-09 | Diplomatura en Sanitat (Sanitat)
Education
Source: Self-asserted source
maria rosa ballester

Universitat de Barcelona: Barcelona, Catalunya, ES

1992-09 to 1998-11-08 | Licenciatura en Farmacia (Farmàcia)
Education
Source: Self-asserted source
maria rosa ballester

Works (17)

An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol [version 1; peer review: 2 approved]

2022-05-05 | Journal article
DOI: 10.12688/gatesopenres.13615.1
Part of ISSN: 2572-4754
Funded by GRANT_NUMBER:

LE-135-19

Funded by GRANT_NUMBER:

RIA2017NCT-1845 –STOP, PSIA2020-3072 STOP-2
Contributors: Alejandro Krolewiecki; Wendemagegn Enbiale; Javier Gandasegui; Lisette van Lieshout; Stella Kepha; Augusto Messa Junior; Michel Bengtson; Woyneshet Gelaye; Valdemiro Escola; María Martinez-Valladares et al.
Source: check_circle
Gates Open Research

Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers

PLoS Neglected Tropical Diseases
2018 | Journal article
DOI: 10.1371/journal.pntd.0006020
EID:

2-s2.0-85041748932
Contributors: Muñoz, J.; Ballester, M.R.; Antonijoan, R.M.; Gich, I.; Rodríguez, M.; Colli, E.; Gold, S.; Krolewiecki, A.J.
Source: Self-asserted source
maria rosa ballester via Scopus - Elsevier

Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.

2016-07 | Journal article
DOI: 10.1093/ijnp/pyw016
PMID: 26874330
PMC: PMC4966277
Contributors: Maqueda AE; Valle M; Addy PH; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; González M; Claramunt J et al.
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.

2015 | Journal article
DOI: 10.2147/dddt.s86300
PMID: 26273191
PMC: PMC4532344
Contributors: Ballester MR; Roig E; Gich I; Puntes M; Delgadillo J; Santos B; Antonijoan RM
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Ibuprofen lysinate, quicker and less variable: relative bioavailability compared to ibuprofen base in a pediatric suspension dosage form.

2015-11 | Journal article
DOI: 10.5414/cp202368
PMID: 26249766
Contributors: Ferrero-Cafiero JM; Gich I; Puntes M; Martínez J; Ballester MR; Coimbra J; Mathison Y; Tarré M; Font X; Antonijoan RM
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates.

2015-08 | Journal article
DOI: 10.1186/s12936-015-0817-x
PMID: 26245196
PMC: PMC4527105
Contributors: Gómez-Pérez GP; Legarda A; Muñoz J; Sim BK; Ballester MR; Dobaño C; Moncunill G; Campo JJ; Cisteró P; Jimenez A et al.
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Stress assessment based on EEG univariate features and functional connectivity measures.

2015-07 | Journal article
DOI: 10.1088/0967-3334/36/7/1351
PMID: 26015439
Contributors: Alonso JF; Romero S; Ballester MR; Antonijoan RM; Mañanas MA
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans.

2015-06 | Journal article
DOI: 10.1093/ijnp/pyv065
PMID: 26047623
PMC: PMC4675976
Contributors: Maqueda AE; Valle M; Addy PH; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; González M; Claramunt J et al.
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.

2015-03 | Journal article
DOI: 10.1186/s12936-015-0628-0
PMID: 25889522
PMC: PMC4371633
Contributors: Mordmüller B; Supan C; Sim KL; Gómez-Pérez GP; Ospina Salazar CL; Held J; Bolte S; Esen M; Tschan S; Joanny F et al.
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Pharmacodynamics assessment of Bemiparin after multiple prophylactic and single therapeutic doses in adult and elderly healthy volunteers and in subjects with varying degrees of renal impairment

Thrombosis Research
2014-06 | Journal article
DOI: 10.1016/j.thromres.2014.03.038
Contributors: Salvador Rico; Rosa-María Antonijoan; Maria Rosa Ballester; Ibon Gutierro; Ignacio Ayani; Javier Martinez-Gonzalez; Montserrat Borrell; Jordi Fontcuberta; Ignasi Gich
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trials.

2014-03 | Journal article
DOI: 10.1002/hup.2378
PMID: 24395298
Contributors: García-Gea C; Martínez J; Ballester MR; Gich I; Valiente R; Antonijoan RM
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Pharmacology of ayahuasca administered in two repeated doses.

2012-02 | Journal article
DOI: 10.1007/s00213-011-2434-x
PMID: 21842159
Contributors: Dos Santos RG; Grasa E; Valle M; Ballester MR; Bouso JC; Nomdedéu JF; Homs R; Barbanoj MJ; Riba J
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.

2010-06 | Journal article
DOI: 10.1111/j.1365-2125.2010.03648.x
PMID: 20565458
PMC: PMC2883759
Contributors: García-Gea C; Ballester MR; Martínez J; Antonijoan RM; Donado E; Izquierdo I; Barbanoj MJ
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

A bioavailability/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation.

2009-05 | Journal article
DOI: 10.1111/j.1440-1681.2008.05089.x
PMID: 19673928
Contributors: Barbanoj MJ; Ballester MR; Antonijoan RM; Puntes M; Gropper S; Santos B; Albet C; Guglietta A
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Comparison of repeated-dose pharmacokinetics of prolonged-release and immediate-release torasemide formulations in healthy young volunteers.

2009-02 | Journal article
DOI: 10.1111/j.1472-8206.2008.00643.x
PMID: 19267775
Contributors: Barbanoj MJ; Ballester MR; Antonijoan RM; Gich I; Pelagio P; Gropper S; Santos B; Guglietta A
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Different acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteers.

2007 | Journal article
DOI: 10.1159/000108379
PMID: 17878744
Contributors: Barbanoj MJ; Urbano G; Antonijoan R; Ballester MR; Valle M
Source: Self-asserted source
maria rosa ballester via Europe PubMed Central
grade
Preferred source (of 2)‎

Therapeutic use of cannabis for the prevention of antineoplastic chemotherapy induced nausea and vomiting (II),L'ús terapèutic del cannabis en la profilaxi i el tractament de nàusees i vòmits associats a la quimioteràpia antineoplàsica (II)

Circular Farmaceutica
2002 | Journal article
EID:

2-s2.0-0036335318
Contributors: Ballester Verneda, M.R.
Source: Self-asserted source
maria rosa ballester via Scopus - Elsevier
How many people are using ORCID?